Personal information

Activities

Education and qualifications (1)

Umberto I Policlinico di Roma: Roma, Lazio, IT

2013-08-08 to present | M.D (Medical Oncology)
Education
Source: Self-asserted source
ARSELA PRELAJ

Works (22)

Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Current Oncology
2024-03-29 | Journal article
Contributors: Denis Horgan; Marc Van den Bulcke; Umberto Malapelle; Nicola Normanno; Ettore D. Capoluongo; Arsela Prelaj; Carmelo Rizzari; Aliki Stathopoulou; Jaya Singh; Marta Kozaric et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Healthcare
2024-01-19 | Journal article
Contributors: Denis Horgan; Marc Van den Bulcke; Umberto Malapelle; Nicola Normanno; Ettore D. Capoluongo; Arsela Prelaj; Carmelo Rizzari; Aliki Stathopoulou; Jaya Singh; Marta Kozaric et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Mobilising Collaboration among Stakeholders to Optimise the Growing Potential of Data for Tackling Cancer

Journal of Molecular Pathology
2023-10-27 | Journal article
Contributors: Denis Horgan; Marc Van den Bulcke; Umberto Malapelle; Nicola Normanno; Ettore D. Capoluongo; Arsela Prelaj; Carmelo Rizzari; Aliki Stathopoulou; Jaya Singh; Marta Kozaric et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

Journal for ImmunoTherapy of Cancer
2023-06 | Journal article
Contributors: Giuseppe Lo Russo; Arsela Prelaj; James Dolezal; Teresa Beninato; Luca Agnelli; Tiziana Triulzi; Alessandra Fabbri; Daniele Lorenzini; Roberto Ferrara; Marta Brambilla et al.
Source: check_circle
Crossref

The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

Clinical Lung Cancer
2023-06 | Journal article
Contributors: Arsela Prelaj; Monica Ganzinelli; Francesco Trovo’; Laila C. Roisman; Alessandra Laura Giulia Pedrocchi; Sokol Kosta; Marcello Restelli; Emilia Ambrosini; Massimo Broggini; Gabriella Pravettoni et al.
Source: check_circle
Crossref

Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy

Cancers
2022-01-16 | Journal article
Contributors: Arsela Prelaj; Mattia Boeri; Alessandro Robuschi; Roberto Ferrara; Claudia Proto; Giuseppe Lo Russo; Giulia Galli; Alessandro De Toma; Marta Brambilla; Mario Occhipinti et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma

Tumori Journal
2021-12 | Journal article
Contributors: Leonardo Provenzano; Valeria Cuccarini; Marco Platania; Luca Canziani; Andrea Spagnoletti; Fabio M. Doniselli; Marica Eoli; Arsela Prelaj; Elena Anghileri
Source: check_circle
Crossref

Machine Learning to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy Using Real World and Translational Data

2021-09-14 | Preprint
Contributors: Arsela Prelaj; Mattia Boeri; Alessandro Robuschi; Roberto Ferrara; Claudia Proto; Giuseppe Lo Russo; Giulia Galli; Alessandro De Toma; Marta Brambilla; Mario Occhipinti et al.
Source: check_circle
Crossref

Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors

Journal of Personalized Medicine
2021-05 | Journal article | Author
Contributors: Mario Occhipinti; Marta Brambilla; Giulia Galli; Sara Manglaviti; Maristella Giammaruco; ARSELA PRELAJ; Roberto Ferrara; Alessandro De Toma; Claudia Proto; Teresa Beninato et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake

Critical Reviews in Oncology/Hematology
2021-04 | Journal article
Contributors: Alessandro De Toma; Giuseppe Lo Russo; Diego Signorelli; Filippo Pagani; Giovanni Randon; Giulia Galli; Arsela Prelaj; Roberto Ferrara; Claudia Proto; Monica Ganzinelli et al.
Source: check_circle
Crossref

Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer

European Journal of Cancer
2019 | Journal article
EID:

2-s2.0-85057838276

Contributors: Prelaj, A.; Tay, R.; Ferrara, R.; Chaput, N.; Besse, B.; Califano, R.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

<sup>223</sup>Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature

Aging Clinical and Experimental Research
2018 | Journal article
EID:

2-s2.0-85028589129

Contributors: De Vincentis, G.; Follacchio, G.A.; Frantellizzi, V.; Prelaj, A.; Farcomeni, A.; Giuli, A.; Bianco, V.; Tomao, S.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Clinical Lung Cancer
2018 | Journal article
EID:

2-s2.0-85058417112

Contributors: Passaro, A.; Prelaj, A.; Bonanno, L.; Tiseo, M.; Tuzi, A.; Proto, C.; Chiari, R.; Rocco, D.; Genova, C.; Sini, C. et al.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Current and future therapeutic approaches for the treatment of small cell lung cancer

Expert Review of Anticancer Therapy
2018 | Journal article
EID:

2-s2.0-85045296183

Contributors: Rossi, A.; Tay, R.; Chiramel, J.; Prelaj, A.; Califano, R.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Immune checkpoint blockade for advanced non-small cell lung cancer: Challenging clinical scenarios

Journal of Thoracic Disease
2018 | Journal article
EID:

2-s2.0-85047762436

Contributors: Tay, R.; Prelaj, A.; Califano, R.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: Case report and review of the literature

Oncology Letters
2018 | Journal article
EID:

2-s2.0-85044667083

Contributors: Prelaj, A.; Rebuzzi, S.E.; Caffarena, G.; Berrìos, J.R.G.; Pecorari, S.; Fusto, C.; Caporlingua, A.; Caporlingua, F.; Di Palma, A.; Magliocca, F.M. et al.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients

Drugs of Today
2017 | Journal article
EID:

2-s2.0-85032954662

Contributors: Passaro, A.; Prelaj, A.; Pochesci, A.; Spitaleri, G.; Rossi, G.; Del Signore, E.; Catania, C.; De Marinis, F.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC

ERS Monograph
2017 | Journal article
EID:

2-s2.0-85032071663

Contributors: Prelaj, A.; Rebuzzi, S.E.; Del Bene, G.; Berrìos, J.R.G.; Emiliani, A.; de Filippis, L.; Prete, A.A.; Pecorari, S.; Manna, G.; Ferrara, C. et al.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

IL-18 receptor marks functional CD8<sup>+</sup> T cells in non-small cell lung cancer

OncoImmunology
2017 | Journal article
EID:

2-s2.0-85021447409

Contributors: Timperi, E.; Focaccetti, C.; Gallerano, D.; Panetta, M.; Spada, S.; Gallo, E.; Visca, P.; Venuta, F.; Diso, D.; Prelaj, A. et al.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

94P: First-line treatment with cisplatin plus etoposide for small cell lung cancer and large cell neuroendocrine carcinoma: Our center experience

Journal of Thoracic Oncology
2016 | Journal article
EID:

2-s2.0-85044283713

Contributors: Bene, G.D.; Prelaj, A.; Berrios, J.R.G.; Filippis, L.D.; Emiliani, A.; Galletti, A.; Ferrara, C.; Longo, F.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Neoadjuvant chemotherapy in neuroendocrine bladder cancer: A case report

American Journal of Case Reports
2016 | Journal article
EID:

2-s2.0-84963630998

Contributors: Prelaj, A.; Rebuzzi, S.E.; Magliocca, F.M.; Speranza, I.; Corongiu, E.; Borgoni, G.; Perugia, G.; Liberti, M.; Bianco, V.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Esophageal stenosis: A differential diagnosis between esophageal cancer and metastasis from other neoplasia

Anticancer Research
2014 | Journal article
EID:

2-s2.0-84897020978

Contributors: Paris, I.; Prelaj, A.; Onesti, C.E.; Baldoni, A.; Giovagnoli, M.R.; Bassanelli, M.; Lauro, S.; Marchetti, P.
Source: Self-asserted source
ARSELA PRELAJ via Scopus - Elsevier

Peer review (1 review for 1 publication/grant)

Review activity for Nature cancer. (1)